• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

2024 United States Breast Cancer Outlook

News
Article

Breast cancer predictions for this year.

Invasive female breast cancer has been rising by nearly 0.6% per year since the mid-2000s, according to a recent report by the American Cancer Society. This is partly due to an overall increase in body weight in women and a change in birth patterns – women are waiting longer to have children and having fewer. The increase in cases is also slightly higher in women under 50 than those over 50 (1% per year vs. 0.5% per year) judging by data collected from 2012 to 2019.

Although breast cancer diagnoses are happening earlier, there has been a sharp decline in cases. The death rate peaked in 1989 and has declined by 42% as of 2021. This can be attributed to early detection, improved treatment and greater breast cancer awareness.

The following information was gathered from the American Cancer Society’s Cancer Facts and Figures: 2024.

© 2024 MJH Life Sciences

All rights reserved.